Anti-hyperalgesic effect of systemic magnesium sulfate in carrageenan-induced inflammatory pain in rats: Influence of the nitric oxide pathway

Magnesium Research

Volumn 27, Issue 2, 2014, Pages 77-85

  Srebro, Dragana P ^a   Vučković, Sonja ^a   Vujović, Katarina Savić ^a   Prostran, Milica ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Carrageenan; Inflammatory pain; Magnesium sulfate; Nitric oxide

Indexed keywords

ARGININE; MAGNESIUM SULFATE; N (G) NITROARGININE METHYL ESTER; NITRIC OXIDE; UNCLASSIFIED DRUG; ANALGESIC AGENT; CARRAGEENAN; N(G) NITROARGININE METHYL ESTER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; ELECTRONIC PRESSURE METER TEST; EXPERIMENTAL TEST; HYPERALGESIA; INFLAMMATORY PAIN; MECHANICAL STIMULATION; NONHUMAN; PAIN THRESHOLD; RAT; SIGNAL TRANSDUCTION; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DOSE RESPONSE; MALE; METABOLISM; PAIN; STIMULATION; WISTAR RAT;

RATTUS;

ANALGESICS, NON-NARCOTIC; ANIMALS; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; MAGNESIUM SULFATE; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PAIN; PHYSICAL STIMULATION; RATS; RATS, WISTAR;

EID: 84907153245     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2014.0364     Document Type: Article

References (37)

1. Herroeder S, Schönherr ME, De Hert SG, Hollmann MW. Magnesium essentials for anesthesiologists. Anesthesiology 2011; 114: 971-93.
2. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999; 83: 302-20.
3. McCarthy RJ, Kroin JS, Tuman KJ, Penn RD, Ivankovich AD. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats. Anesth Analg 1998; 86: 830-6.
4. Liu HT, Hollmann MW, Liu WH, Hoenemann CW, Durieux ME. Modulation of NMDA receptor function by ketamine and magnesium: Part I. Anesth Analg 2001; 92: 1173-81.
5. Nechifor M. Magnesium involvement in pain. Magnes Res 2011; 24: 220-2.
6. Morrison AP, Hunter JM, Halpern SH, Banerjee A. Effect of intrathecal magnesium in the presence or absence of local anaesthetic with and without lipophilic opioids: a systematic review and metaanalysis. Br J Anaesth 2013; 110: 702-12.
7. Begon S, Pickering G, Eschalier A, Dubray C. Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain Res 2000; 887: 436-9.
8. Rondón LJ, Privat AM, Daulhac L, et al. Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain. J Physiol 2010; 588: 4205-15.
9. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992; 51: 5-17.
10. Ishizaki K, Sasaki M, Karasawa S, Obata H, Nara T, Goto F. The effect of intrathecal magnesium sulfate on nociception in rat acute pain models. Anaesthesia 1999; 54: 241-6.
11. Takano Y, Sato E, Kaneko T, Sato I. Antihyperalgesic effects of intrathecally administered magnesium sulfate in rats. Pain 2000; 84: 175-9.
12. Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 2006; 22: 471-6.
13. Ren K, Williams GM, Hylden JL, Ruda MA, Dubner R. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Eur J Pharmacol 1992a; 219: 235-43.
14. Lawand NB, McNearney T, Westlund KN. Amino acid release into the knee joint: key role in nociception and inflammation. Pain 2000; 86: 69-74.
15. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg 2003; 97: 1108-16.
16. Du J, Zhou S, Coggeshall RE, Carlton SM. N-methylD-aspartate-induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience 2003; 118: 547-62.
17. Freire MA, Guimarães JS, Leal WG, Pereira A. Pain modulation by nitric oxide in the spinal cord. Front Neurosci 2009; 3: 175-81.
18. Kawamata T, Omote K. Activation of spinal N-methyl-D-aspartate receptors stimulates a nitric oxide/cyclic guanosine 3,5-monophosphate/ glutamate release cascade in nociceptive signaling, while a high dose of zymosan appears to disturb it. Anesthesiology 1999; 9: 1415-24.
19. Tanabe M, Nagatani Y, Saitoh K, Takasu K, Ono H. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacology 2009; 56: 702-8.
20. Vučković S, Tomić M, Stepanović-Petrović R, Ugrešić N, Prostran M, Bošković B. Peripheral antinociception by carbamazepine in an inflammatory mechanical hyperalgesia model in the rat: a new target for carbamazepine? J Pharmacol Sci 2006; 100: 310-4.
21. Begon S, Pickering G, Eschalier A, Dubray C. Magnesium increases morphine analgesic effect in different experimental models of pain. Anesthesiology 2002; 96: 627-32.
22. Ren K, Hylden JL, Williams GM, Ruda MA, Dubner R. The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain 1992b; 50: 331-44.
23. Xiao WH, Bennett GJ. Magnesium suppresses neuropathic pain responses in rats via a spinal site of action. Brain Res 1994; 666: 168-72.
24. Gupta LK, Gupta R, Tripathi CD. N-methyl-Daspartate receptor modulators block hyperalgesia induced by acute low-dose morphine. Clin Exp Pharmacol Physiol 2011; 38: 592-7.
25. Yamaguchi H, Naito H. Antinociceptive synergistic interaction between morphine and n omega-nitro 1-arginine methyl ester on thermal nociceptive tests in the rats. Can J Anaesth 1996; 43: 975-81.
26. Karaaslan D, Arslan G. The role of nitric oxide on the potentiating effect of magnesium on morphine analgesia. Acta Anaesthesiol Scand 2005; 49: 129.
27. Kawabata A, Manabe S, Manabe Y, Takagi H. Effect of topical administration of Larginine on formalininduced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 1994; 112: 547-50.
28. Zhang XC, Zhang YQ, Zhao ZQ. Different roles of two nitric oxide activated pathways in spinal longterm potentiation of C-fiber-evoked field potentials. Neuropharmacology 2006; 50: 748-54.
29. Granados-Soto V, Rufino MO, Gomes Lopes LD, Ferreira SH. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur J Pharmacol 1997; 340: 177-80.
30. Bulutcu F, Dogrul A, Güç MO. The involvement of nitric oxide in the analgesic effects of ketamine. Life Sci 2002; 7: 841-53.
31. Sachs D, Cunha FQ, Ferreira SH. Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proc Natl Acad Sci U S A 2004; 101: 3680-5.
32. Garrido-Suárez BB, Garrido G, Márquez L, et al, Bosch F. Pre-emptive anti-hyperalgesic effect of electroacupuncture in carrageenan-induced inflammation: role of nitric oxide. Brain Res Bull 2009; 79: 339-44.
33. Galdino GS, Cortes SF, Duarte ID, Perez AC. Involvement of the nitric oxide/(C)GMP/K(ATP) pathway in antinociception induced by exercise in rats. Life Sci 2010; 86: 505-9.
34. Yonehara N, Takemura M, Yoshimura M, et al. Nitric oxide in the rat spinal cord in Freund’s adjuvant-induced hyperalgesia. Jpn J Pharmacol 1997; 75: 327-35.
35. De Alba J, Clayton NM, Collins SD, Colthup P, Chessell I, Knowles RG. GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain 2006; 120: 170-81.
36. Milovanović M, Vučković S, Prostran M, Jezdimirović M, Čupić M. The effects of flunixin meglumine and L-NAME on the carrageenaninduced hyperalgesia in rats. Basic Clin Pharmacol Toxicol 2009; 105: 62.
37. Cardoso CC, Lobato KR, Binfaré RW, et al. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 235-42.